Cheryl A London, DVM, PhD
College of Veterinary Medicine
>Cancer ● Osteosarcoma ● Lymphoma ● Melanoma ● Histiocytic Sarcoma ● Carcinoma, Squamous Cell ● Lymphoma, Non-Hodgkin ● Thyroid Cancer
As a veterinarian, Cheryl London, DVM, PhD, brings a special perspective to the Translational Therapeutics Program at the OSUCCC – James.Her research focuses on using spontaneous tumors in dogs and cats as models for human cancer. In addition, she is investigating kinase dysfunction in animal tumors and mouse models of Kit gene dysregulation. One of her recent studies indicates that the turnover of hyaluronan, which is an anionic, non-sulfated glycosaminoglycan, has a critical role in the development of canine mast cell tumors (CMCT). Dr. London has co-authored many articles that have appeared in such well-respected publications as Molecular Cancer Therapeutics, Veterinary and Comparative Oncology and BMC Veterinary Research.